Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Optinose Inc
(NQ:
OPTN
)
4.450
USD
+0.340 (+8.27%)
Official Closing Price
Updated: 7:27 PM EST, Jan 25, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Optinose Inc
< Previous
1
2
3
4
5
6
7
8
Next >
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
March 03, 2019
It was an event-filled one for biotech stocks, with the release of a slew of earnings, presentations of clinical trial results and ...
Tags
ALBO
GERN
EVOK
From
Benzinga
Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019
February 26, 2019
Conference Call and Webcast Scheduled for Wednesday, March 6 at 8:00 a.m. Eastern Time
From
GlobeNewswire News Releases
EQWS's Underlying Holdings Imply 22% Gain Potential
February 22, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Optinose Announces Issuance of Four Additional U.S. Patents Covering XHANCE
February 18, 2019
XHANCE Now Covered by 13 Orange Book-Listed Patents
From
GlobeNewswire News Releases
Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco
February 14, 2019
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will present clinical and health economic...
From
GlobeNewswire News Releases
Optinose Announces License Agreement
February 03, 2019
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
From
GlobeNewswire News Releases
Sosei Heptares Announces Medicxi to Invest Up To €40 Million in New Collaboration Based on its Orexin Agonist Program
February 03, 2019
Two newly created asset-centric companies, Orexia Limited and Inexia Limited, to develop novel therapies for neurological diseases
From
PR Newswire
Look Under The Hood: IBB Has 32% Upside
January 21, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
50 Biggest Movers From Monday
January 01, 2019
Gainers Lincoln Educational Services Corporation (NASDAQ: LINC) shares climbed 45.45 percent to close at $3.20 on Monday. China ...
Tags
ADAP
MRKR
Movers From Monday
From
Benzinga
33 Stocks Moving In Monday's Mid-Day Session
December 31, 2018
Gainers vTv Therapeutics Inc. (NASDAQ: VTVT) shares surged 36.6 percent to $3.10 after closing up 120 percent last Friday after ...
Tags
Movers & Shakers
Markets
KOD
From
Benzinga
The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial
December 20, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ...
Tags
APLS
CKPT
SNOA
From
Benzinga
The Math Shows PBSM Can Go To $33
December 19, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
December 19, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ...
Tags
RSLS
CDTX
OPTN
From
Benzinga
The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas
December 18, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stocks hit 52-week highs ...
Tags
CMRX
VBLT
Market News
From
Benzinga
45 Biggest Movers From Yesterday
December 18, 2018
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 66.28 percent to close at $1.14 on Tuesday after the company entered a ...
Tags
ACIU
CGIX
Trading Ideas
From
Benzinga
The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen
December 12, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. No biotech stock hit 52-week high in ...
Tags
Benzinga
UMRX
News
From
Benzinga
Investor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group — Discovering Underlying Factors of Influence
December 10, 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of eBay Inc. (NASDAQ:EBAY),...
From
GlobeNewswire News Releases
Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAIL
December 10, 2018
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company received written notice from Avanir...
From
GlobeNewswire News Releases
Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis
December 09, 2018
Company also announces first patient enrolled in clinical trial of XHANCE for treatment of nasal polyps in pediatric patients
From
GlobeNewswire News Releases
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
December 05, 2018
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will...
From
GlobeNewswire News Releases
52 Biggest Movers From Friday
December 02, 2018
Gainers Borqs Technologies, Inc (NASDAQ: BRQS) shares gained 122.66 percent to close at $5.70 on Friday. Tel-Instrument ...
Tags
UXIN
CASI
Pre/Market Outlook
From
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
November 30, 2018
Gainers Determine, Inc. (NASDAQ: DTRM) shares jumped 78.7 percent to $0.84. Tel-Instrument Electronics Corp. (NYSE: TIK) shares ...
Tags
UTI
AVAV
SFM
From
Benzinga
The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial
November 26, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ...
Tags
VCEL
Offerings
Biotech
From
Benzinga
The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO
November 21, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ...
Tags
AQST
DRRX
CTIC
From
Benzinga
Analysts Expect EQWS Will Reach $53
November 19, 2018
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
OptiNose, Inc. (OPTN) Q3 2018 Earnings Conference Call Transcript
November 13, 2018
OPTN earnings call for the period ending September 30, 2018.
Tags
OPTN
Market News
From
Motley Fool
The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut
November 12, 2018
Here's a roundup of top developments in the biotech space over the last 24 hours. None of the Nasdaq-listed biotech stocks hit ...
Tags
CYCC
AERI
CUR
From
Benzinga
Optinose Reports Third Quarter 2018 Financial Results and Recent Operational Highlights
November 12, 2018
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended September 30,...
From
GlobeNewswire News Releases
Short Interest Makes 19.6% Move For OPTN
November 12, 2018
The most recent short interest data has been released for the 10/31/2018 settlement date, which shows a 1,079,926 share increase in total short interest for OptiNose Inc (OPTN), to 6,588,652, an...
Tags
Stocks
From
Market News Video
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
November 11, 2018
Earnings and U.S. midterm polls continued to positively influence biotech stocks, with the sector notching gains for the second ...
Tags
FCSC
TBPH
VAPO
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.